Comments on: Landmark Analysis Shows Continuous Treatment With REVLIMID(R) Plus Dexamethasone Significantly Increases Overall Survival In Multiple Myeloma Patients

Comments on: Landmark Analysis Shows Continuous Treatment With REVLIMID(R) Plus Dexamethasone Significantly Increases Overall Survival In Multiple Myeloma Patients http://www.druginformations.org/medicine_news/2008/12/11/landmark-analysis-shows-continuous-treatment-with-revlimidr-plus-dexamethasone-significantly-increases-overall-survival-in-multiple-myeloma-patients/ Your best medicine news resource Tue, 16 Mar 2010 01:51:53 +0000 http://wordpress.org/?v=2.1.2